An inhalational antiviral strategy for the potential use of nitric oxide during influenza infection
Since the discovery in the late 1980’s that the endothelium relaxing factor is nitric oxide (NO) there has been intensive scientific pursuit to understand the many roles of NO in biological systems. NO is a messenger molecule with both paracrine and autocrine functions. NO is produced by phagocytes...
Main Author: | McMullin, Bevin Brent |
---|---|
Language: | English |
Published: |
University of British Columbia
2012
|
Online Access: | http://hdl.handle.net/2429/43212 |
Similar Items
-
An inhalational antiviral strategy for the potential use of nitric oxide during influenza infection
by: McMullin, Bevin Brent
Published: (2012) -
An inhalational antiviral strategy for the potential use of nitric oxide during influenza infection
by: McMullin, Bevin Brent
Published: (2012) -
Inhaled Nitric Oxide Therapy Fails to Improve Outcome in Experimental Severe Influenza
by: Ilyse Darwish, Chris Miller, Kevin C. Kain, W. Conrad Liles
Published: (2012-01-01) -
Weaning of inhaled nitric oxide: is there a best strategy?
by: Anita M. Ware, et al.
Published: (2015-04-01) -
Update on the Use of Inhaled Nitric Oxide
by: Robert M Kacmarek
Published: (1996-01-01)